Close
Select up to 3 companies
| Company |
Intrexon Corporation
|
|
|
|
|---|---|---|---|---|
| Short Description | Developer of synthetic biology technology solutions for different industries including energy, food, water and medicine |
|
|
|
| Status | Public |
|
|
|
| Year Founded | 1998 |
|
|
|
| Industry Group |
|
|
|
|
| Sector |
|
|
|
|
| TRL Range | 9 |
|
|
|
| Country | United States |
|
|
|
| Nbr Employees | 101-250 |
|
|
|
| Revenue Range |
|
|
|
|
|
Total Equity Capital Raised |
$367.4M |
|
|
|
|
Last Stage Capital Raised |
Follow-on Public Offering
round of
$200M
2018 |
|
|
|
| Investors | Third Security, Randal J. Kirk, NewVa Capital Partners, Virginia Tech |
|
|
|
Investment Data Information
Investment data is not editable by profile owners.
Please contact research@cleantech.com to make changes.
Close
Hey there!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
Startups
Use i3 to gain visibility with corporations and investors looking to invest and partner with external technology companies.
Contact us
Use i3 to access market intelligence on companies, investors, market activity and innovation trends.
Are you involved with a startup or SME looking for strategic partners, investors, or customers? Create your free profile!
Contact us to discuss the full power of i3:
Close
Request Received!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Get in touch
Message
Traction
Similar companies
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Back to top